Back to search
FDAFDA · Food and drugs·Recall number D-1291-2014

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 7.5 mg for 1-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3642-03, UPC 3 00743 64203 2.

Published May 7, 2014 · Recall initiated: March 10, 2014

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
LUPRON DEPOT
Manufacturer
AbbVie Inc
Distributor
Nationwide and Puerto Rico
UPC
300743642032
Lot
Lot #: 1012381, 1012383, Exp 08/22/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card